Delcath Systems Inc. | Ownership
Companies that own Delcath Systems Inc.
Hudson Bay Capital Management LP
19,656
2.11%
19,656
0%
12/31/2017
Invesco Capital Management LLC
216
0.02%
0
0%
09/05/2018
Gemmer Asset Management LLC
1
0%
1
0%
06/30/2018
Renaissance Technologies LLC
0
0%
-1
0%
12/29/2017
West Oak Capital LLC
0
0%
-50
0%
06/30/2018
| Address |
1633 Broadway
New York New York 10019
United States
|
|
Employees
|
- |
| Website |
http://www.delcath.com |
| Updated |
07/08/2019 |
| Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes Melphalan Hydrochloride for Injection, which is a proprietary product for use with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY. |
